Cargando…
Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters
To generate an inexpensive readily manufactured COVID-19 vaccine, we employed the LVS ΔcapB vector platform, previously used to generate potent candidate vaccines against Select Agent diseases tularemia, anthrax, plague, and melioidosis. Vaccines expressing SARS-CoV-2 structural proteins are constru...
Autores principales: | Jia, Qingmei, Bielefeldt-Ohmann, Helle, Maison, Rachel M., Masleša-Galić, Saša, Cooper, Sarah K., Bowen, Richard A., Horwitz, Marcus A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009914/ https://www.ncbi.nlm.nih.gov/pubmed/33785745 http://dx.doi.org/10.1038/s41541-021-00321-8 |
Ejemplares similares
-
Oral Administration of Universal Bacterium-Vectored Nucleocapsid-Expressing COVID-19 Vaccine is Efficacious in Hamsters
por: Jia, Qingmei, et al.
Publicado: (2023) -
Listeria-vectored multi-antigenic tuberculosis vaccine protects C57BL/6 and BALB/c mice and guinea pigs against Mycobacterium tuberculosis challenge
por: Jia, Qingmei, et al.
Publicado: (2022) -
Listeria-Vectored Multiantigenic Tuberculosis Vaccine Enhances Protective Immunity against Aerosol Challenge with Virulent Mycobacterium tuberculosis in BCG-Immunized C57BL/6 and BALB/c Mice
por: Jia, Qingmei, et al.
Publicado: (2022) -
Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia
por: Jia, Qingmei, et al.
Publicado: (2018) -
Infection, Replication, and Transmission of Middle East Respiratory Syndrome Coronavirus in Alpacas
por: Adney, Danielle R., et al.
Publicado: (2016)